Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study

Cerebrolysin over 4 weeks is safe and effective for the improvement of CSM as compared with placebo, with no reported cases of neurologic deterioration over 6 months of follow-up.